Related Experiment Video
Updated: Mar 7, 2026
05:59
Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
3.2K
Hypersomnolence, Hypersomnia, and Mood Disorders
Lucie Barateau1,2,3, Régis Lopez1,2,3, Jean Arthur Micoulaud Franchi4,5,6
1Sleep-Wake Disorders Center, Department of Neurology, Gui-de-Chauliac Hospital, CHU Montpellier, 80 avenue Augustin Fliche, 34295, Montpellier Cedex 5, France.
Current Psychiatry Reports
|March 1, 2017
Summary
Differentiating hypersomnolence in psychiatric patients is complex. Objective sleepiness is rare in mood disorders, while central hypersomnia disorders often present with psychiatric symptoms, challenging diagnosis.
Area of Science:
- Neurology
- Psychiatry
- Sleep Medicine
Background:
- Hypersomnolence is frequently reported in psychiatric disorders, particularly mood disorders.
- Patients with mood disorders and hypersomnolence often lack objective daytime sleepiness on the Multiple Sleep Latency Test.
- Psychiatric comorbidities, especially depression, are common in hypersomnia disorders.
Purpose of the Study:
- To explore the complex relationship between hypersomnolence, psychiatric disorders, and primary hypersomnia disorders.
- To highlight the diagnostic challenges in differentiating psychiatric hypersomnolence from central hypersomnia disorders with psychiatric symptoms.
Main Methods:
- Review of existing literature on hypersomnolence, mood disorders, and hypersomnia disorders.
- Discussion of diagnostic limitations and the role of objective sleep testing.
Main Results:
- Hypersomnolence in psychiatric patients may have iatrogenic causes or be linked to conditions like sleep apnea syndrome.
- Central hypersomnia disorders can exhibit endogenous psychiatric symptoms, complicating differential diagnosis.
- Current diagnostic tools face limitations in distinguishing between these conditions.
Conclusions:
- The distinction between psychiatric hypersomnolence and central hypersomnia disorders with psychiatric comorbidities is a significant clinical challenge.
- Further research is essential to improve diagnostic accuracy and management strategies for these complex cases.
Keywords:
DepressionExcessive daytime sleepinessHypersomniaHypersomnolenceIdiopathic hypersomniaMoodNarcolepsy type 1Narcolepsy type 2Psychiatric disordersMore Related Videos
Related Concept Videos
01:07Narcolepsy
669
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
669
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
737
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
737
01:19Management of Insomnia
745
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
745
01:17Sleepwalking and Sleep Talking
1.2K
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
1.2K
01:24Sleep-Wake Cycles
3.1K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
3.1K
01:27Insomnia
560
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
560